“….[it] highlights once more the extraordinary contributions ERIC makes to the standardization of key laboratory data in CLL including IGHV sequencing, diagnostic flow cytometry, and the detection of minimal residual disease.” (A. Wiestner, Haematologica 2021)

 

IG NETWORK
READ MORE
TP53 NETWORK
READ MORE
RE-CERTIFICATION
READ MORE